Cite
HARVARD Citation
Hsu, L. et al. (n.d.). A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study. American journal of hematology. 93 (12), pp. 1493-1500. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hsu, L. et al. (n.d.). A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study. American journal of hematology. 93 (12), pp. 1493-1500. [Online].